April Rose - Dissemin

Language
Login

All papers authored by April Rose

This paper is made freely available by the publisher.

2021 April A. N. Rose

ORCID

, Susan M. Armstrong, David Hogg, Marcus O. Butler, Samuel D. Saibil, Diana P. Arteaga, Thiago Pimentel Muniz, Deirdre Kelly, Danny Ghazarian, Ian King, Zaid Saeed Kamil, Kendra Ross, Anna Spreafico

ORCID

Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy

Download from doi.org

This paper is made freely available by the publisher.

Ines Pires da Silva

ORCID

, Aljosja Rogiers

ORCID

, Chiara Tentori, Ines Pires Da Silva, Arielle Elkrief, Carlo Alberto Tondini, Neha Papneja, Maria Grazia Vitale, April A. N. Rose

ORCID

, Joseph M. Grimes, Jessica S. W. Borgers, Severine Roy, Joanna Mangana, Megan H. Trager

ORCID

, Thiago Pimentel Muniz and 35 other authors

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2020 Michelle B. Nadler, April A. N. Rose

ORCID

, Rebecca Prince, Lawson Eng, Anthony Lott, Robert C. Grant, Jennifer M. Jones, Katherine Enright

Increasing Referrals of Patients With Gastrointestinal Cancer to a Cancer Rehabilitation Program: A Quality Improvement Initiative

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Matthew Dankner, April A. N. Rose

ORCID

BRAF Mutation Class and Clinical Outcomes—Letter

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

A. A. N. Rose

ORCID

Encorafenib and binimetinib for the treatment of BRAF V600E/K-mutated melanoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Matthew Dankner, Mathieu Lajoie, Dan Moldoveanu, Tan-Trieu Nguyen, Paul Savage, Shivshankari Rajkumar, Xiu Huang, Maria Lvova, Alexei Protopopov, Dana Vuzman, David Hogg, Morag Park, Marie-Christine Guiot, Kevin Petrecca, Catalin Mihalcioiu and 3 other authors

Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas

Upload

This paper was not found in any repository, but could be made available legally by the author.

Matthew Dankner, April A. N. Rose

ORCID

Comment on ‘Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study’

Upload

This paper was not found in any repository, but could be made available legally by the author.

Matthew Dankner, April A. N. Rose

ORCID

, Shivshankari Rajkumar, Peter M. Siegel

ORCID

, Ian R. Watson

Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations

Upload

This paper was not found in any repository, but could be made available legally by the author.

2017 April A. N. Rose

ORCID

, Marco Biondini, Rafael Curiel, Peter M. Siegel

Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer

Upload

This paper is made freely available by the publisher.

2016 April A. N. Rose

ORCID

, Matthew G. Annis

ORCID

, Dennie T. Frederick, Marco Biondini, Zhifeng Dong, Lawrence Kwong, Lynda Chin, Tibor Keler, Thomas Hawthorne, Ian R. Watson, Keith T. Flaherty, Peter M. Siegel

MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB

Download from aacrjournals.org

This paper is made freely available by the publisher.

2015 Sébastien Tabariès, Véronique Ouellet, Brian E. Hsu, Matthew G. Annis

ORCID

, April An Rose

ORCID

, Liliane Meunier, Euridice Carmona, Christine E. Tam, Anne-Marie Mes-Masson, Peter M. Siegel

Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases

Download from link.springer.com

This paper is made freely available by the publisher.

G. Maric, M. G. Annis

ORCID

, Z. Dong, A. A. N. Rose

ORCID

, S. Ng, D. Perkins, P. A. MacDonald, V. Ouellet, C. Russo, P. M. Siegel

GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis

Download from www.nature.com

This paper is available in a repository.

2014 Johanna Bendell, Mansoor Saleh, April A. N. Rose

ORCID

, Peter M. Siegel, Lowell Hart, Surendra Sirpal, Suzanne Jones, Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, Thomas Davis, Linda Vahdat

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer

Download from www.researchgate.net

This paper was not found in any repository, but could be made available legally by the author.

2013 April A. N. Rose

ORCID

, Christine Elser, Marguerite Ennis, Pamela J. Goodwin

Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis

Upload

This paper is made freely available by the publisher.

April An Rose

ORCID

, Peter M. Siegel, Matthew G. Annis

ORCID

, Gordana Maric

Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer

Download from dx.doi.org

This paper is made freely available by the publisher.

2010 April A. N. Rose

ORCID

, Matthew G. Annis

ORCID

, Zhifeng Dong, Francois Pepin, Michael Hallett, Morag Park, Peter M. Siegel

ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties

Download from doi.org

This paper is made freely available by the publisher.

Amandine Bemmo, Christel Dias, April A. N. Rose

ORCID

, Caterina Russo, Peter Siegel, Jacek Majewski

Exon-Level Transcriptome Profiling in Murine Breast Cancer Reveals Splicing Changes Specific to Tumors with Different Metastatic Abilities

Download from doi.org

This paper is available in a repository.

Mélanie Demers, April A. N. Rose

ORCID

, Andrée-Anne Grosset, Katherine Biron-Pain, Louis Gaboury

ORCID

, Peter M. Siegel, Yves St-Pierre

Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells

Download from www.ncbi.nlm.nih.gov

This paper is made freely available by the publisher.

April A. N. Rose

ORCID

, Andrée-Anne Grosset, Zhifeng Dong, Caterina Russo, Patricia A. Macdonald, Nicholas R. Bertos, Yves St-Pierre, Ronit Simantov, Michael Hallett, Morag Park, Louis Gaboury

ORCID

, Peter M. Siegel

Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer

Download from aacrjournals.org

This paper is made freely available by the publisher.

April An N. Rose

ORCID

, Peter M. Siegel

Emerging therapeutic targets in breast cancer bone metastasis

Download from doi.org

Missing publications? Search for publications with a matching author name.